Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
Utah Medical Products (UTMD) announced two key developments: First, the appointment of Carrie Leigh to its Board of Directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Utah Medical Products (UTMD) announced two key developments: First, the appointment of Carrie Leigh to its Board of Directors. Leigh, who worked in direct sales positions for UTMD from 2004 to 2016, brings valuable experience from her role as manager of Global Direct End User Sales. Second, the company increased its quarterly cash dividend by 1.7% to $0.305 per share, payable on January 3, 2025, to shareholders of record as of December 16, 2024.
Positive
- Dividend increase of 1.7% to $0.305 per share
- Strategic board appointment with direct industry sales experience
Negative
- None.
Details
News Market Reaction – UTMD
The recorded move for UTMD in the trading session of this news was -0.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the Board believes her robust understanding of the functional and strategic challenges that the Company faces will be integral for achieving future revenue growth.
In addition, the Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on January 3, 2025 to shareholders of record at the close of business on December 16, 2024. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on accesswire.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.